GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Red White & Bloom Brands Inc (OTCPK:RWBYF) » Definitions » Capex-to-Revenue

Red White & Bloom Brands (Red White & Bloom Brands) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Red White & Bloom Brands Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Red White & Bloom Brands's Capital Expenditure for the three months ended in Dec. 2023 was $0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was $14.34 Mil.

Hence, Red White & Bloom Brands's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.00.


Red White & Bloom Brands Capex-to-Revenue Historical Data

The historical data trend for Red White & Bloom Brands's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Red White & Bloom Brands Capex-to-Revenue Chart

Red White & Bloom Brands Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
- 0.01 0.27 0.05 0.03

Red White & Bloom Brands Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.01 - - -

Competitive Comparison of Red White & Bloom Brands's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Red White & Bloom Brands's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Red White & Bloom Brands's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Red White & Bloom Brands's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Red White & Bloom Brands's Capex-to-Revenue falls into.



Red White & Bloom Brands Capex-to-Revenue Calculation

Red White & Bloom Brands's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.652) / 65.842
=0.03

Red White & Bloom Brands's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 14.344
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Red White & Bloom Brands  (OTCPK:RWBYF) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Red White & Bloom Brands Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Red White & Bloom Brands's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Red White & Bloom Brands (Red White & Bloom Brands) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Red White & Bloom Brands Inc is a multi-state operator in the United States conducting operations in the legal cannabis industry. The principal activity of the company is the sale of a diverse range of high-quality cannabis-based products delivered through its distribution and retail channels. The company operates twelve licensed adult-use and medical retail dispensaries located in the legal states of Michigan and Florida.